Pliant Therapeutics, Inc.
PLRX
$1.07
-$0.01-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.42% | 28.99% | 12.98% | -11.63% | -28.56% |
| Total Depreciation and Amortization | -26.60% | -20.19% | -16.05% | -7.91% | 8.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.60% | -19.12% | -22.88% | -9.97% | -0.31% |
| Change in Net Operating Assets | -13,681.97% | -275.37% | -223.50% | -527.75% | -98.66% |
| Cash from Operations | 43.31% | 17.47% | -19.01% | -23.75% | -49.62% |
| Capital Expenditure | 95.72% | 90.28% | 84.24% | 48.96% | -16.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.05% | -6.71% | 25.76% | 22.92% | 39.94% |
| Cash from Investing | -59.26% | -4.31% | 28.94% | 24.41% | 40.44% |
| Total Debt Issued | -- | -- | -99.99% | -99.99% | -99.99% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.00% | -82.23% | -79.90% | -68.00% | -43.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,858.13% | -237.12% | -97.11% | -95.11% | -92.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -211.91% | -423.65% | -39.73% | -76.10% | -268.72% |